Skip to main content
The Oncologist logoLink to The Oncologist
. 2016 Mar 9;21(4):503–505. doi: 10.1634/theoncologist.2015-0305

Smoking Cessation Support Among Oncology Practitioners in a Regional Cancer Center in the Middle East—Improving a Critical Service for Cancer Care

Nour A Obeidat 1, Hiba S Ayub 2, Rula Amarin 3, Barakat Aburajab Altamimi 4, Iyad Ghonimat 5, Susan Abughosh 6, Feras I Hawari 7,
PMCID: PMC4828116  PMID: 26961922

Abstract

This study examined smoking cessation support (SCS) by oncologists in a Jordanian cancer center and found it to be deficient. Recommendations to improve SCS include improving patient-provider communication and building providers’ self-efficacy through continuing education.

Introduction

Integration of smoking cessation (SC) services within cancer treatment is essential for ensuring better quality of care [13]. Unfortunately, deficiencies exist in the availing, by oncology providers, of SC services [2, 47]. Reasons include lack of professional education, patient resistance, and time barriers [810].

In Middle Eastern countries such as Jordan, a scarcity of information exists with regard to provision of SC support (SCS) among oncology practitioners. Without such information, cancer centers are unable to identify opportunities for improvement. King Hussein Cancer Center (KHCC), which also operates a SC clinic and is a regional SC training center, is one of the few comprehensive cancer centers in the region. We thus sought, within KHCC, to study the status of provider-reported performance of SCS, focusing on provision of AAR (Ask about smoking, Advice against smoking, Refer to the SC clinic, and document smoking status); factors associated with provision of AAR; and perceived roles, barriers, and facilitators of providing SCS.

Methods

By using the Social Cognitive Theory [11] and reviewing other questionnaires that measured SC-related provider perceptions [1215], an Arabic questionnaire was developed. Questions probed practices related to SCS (23 specific actions were measured) and perceptions regarding SC within the context of cancer care. Questionnaire content validity was ensured by sharing the questionnaire with KHCC’s SC clinic staff and by piloting the tool in a group of practitioners (n = 9). The questionnaire was then distributed to staff. A sample size of 99 physicians and 141 nursing/supportive staff was required. (The parameter used in sample size calculation was expected rate of referral to the SC clinic, which internal aggregate data indicate did not exceed 15%. A finite population correction factor was applied.)

Operational measures used during analysis included smoking status (any use of tobacco versus yes/no); age (≤27; >27 years of age, with 27 being the sample’s median age); gender; profession (physician/other); provision of AAR (yes/no: AAR provision was defined as—in >69% of new patients—asking, advising, and referring smokers, and documenting their status); confidence in providing AAR; and perceived importance of SCS.

Descriptive statistics were generated to present sample characteristics, the extent to which SC-related practices were performed, and perceived barriers and facilitators for providing general SCS. Bivariate and multivariable logistic regression analyses were conducted to determine factors that were significantly associated with provision of AAR to cancer patients in the center.

Results

A total of 272 surveys were collected after distributing 452 surveys (60.2% response). An analytic sample of 254 remained after dropping surveys of poor quality. The sample (Table 1) was composed of approximately 41% physicians and 59% supportive staff (largely nursing). Major results included the following.

Table 1.

Characteristics of oncology providers at King Hussein Cancer Center

graphic file with name theoncologist_15305t1.jpg

Roughly half (51.6%) reported providing verbal information on tobacco effects, and 40.2% reported advising patients to quit. Approximately 26% referred smokers to the SC clinic. When asked to approximate the proportion of new patients for which specific activities were performed (Table 2), asking about cigarette use, advising cigarette smokers to quit, and asking about smoking frequency were the most frequently performed activities (in approximately 65% of new patients). Provision declined with activities such as assessing quit desire (49.2%), referring smokers to the SC clinic (47.3%), and continuing to track smokers during follow-up (39.4%). Approximately 21% of practitioners reported provision of AAR. This proportion was 13.8% when AAR was gauged for waterpipe use.

Table 2.

Practices of oncology providers at King Hussein Cancer Center

graphic file with name theoncologist_15305t2.jpg

The majority of providers, 81.7%, felt that SCS for cancer patients was important. Particularly for a selection of basic activities such AAR, the majority (at least 70%) of respondents perceived that these should be part of their role as providers.

Patient-related factors (smokers’ unwillingness to stop, their lower educational status, and their being bothered by discussions regarding SC) were the most frequently—by 70% or more—identified barriers. The relapsing nature of tobacco addiction, medication costs, and time constraints also were frequently (65.0%, 58.6%, and 57%, respectively) cited as barriers. Approximately 66% of providers felt that the presence of a clear mechanism for referral to the SC clinic, having more SC-knowledgeable employees, and improving practitioners’ skills in SC would facilitate provision of SCS.

In multivariate analyses to evaluate factors associated with AAR provision to cigarette smokers, only confidence to provide AAR was significant (Table 3). Similar results were found for provision of AAR to waterpipe smokers (results not presented).

Table 3.

Factors associated with the provision of AAR by health care providers to cancer patients in a regional cancer center in the Middle East: Bivariate and multivariable associations

graphic file with name theoncologist_15305t3.jpg

Discussion

Our study reveals that, although providers in a regional cancer center in the Middle East perform some elements of SCS with high frequency, collective provision of a basic set of tasks such as AAR to cancer patients who smoke is low. Lower rates of provision also were noticeable for actions that needed relatively more provider knowledge or effort. The general underprovision of multiple or more advanced SCS-related tasks we observed was more marked than in other studies [10, 16]. Improving patient-provider communication and building self-efficacy to provide SCS, both of which can be achieved at least in part through continuing education, can increase the provision of AAR.

Despite underprovision of AAR, we also found that most respondents identified the majority of SC-related activities listed as part of their role (although only 34% of providers reported confidence in performing AAR). Given that confidence was the only factor significantly associated with AAR provision, and can be improved through training, availing the latter offers a feasible way of potentially improving SCS. This need is also echoed by the respondents, approximately 66% of whom identified improving skills/education as a facilitator to providing SCS.

The covariates we explored to predict AAR provision did not reach statistical significance in multivariate analyses (our study may have been underpowered to detect a statistical significance). Nevertheless, the direction and magnitude of their effect suggest that educational efforts to improve the provision of SCS should more intensely target smokers, younger staff, and nonphysicians. In particular, with regard to practitioners' smoking status, differences in AAR provision between smokers and nonsmokers were the starkest (7.6% vs. 25.7%; Table 3); and in further analyses (not presented), results trended toward underprovision, across specific tasks, by practitioners who smoked. Thus, our findings also can be used to emphasize the value of institutional measures taken to deter the presence of practitioners who smoke (KHCC imposes strict smoking bans on its premises and offers free SC treatment for its employees).

Finally, with regard to barriers to SCS provision, patient-related barriers were the most frequently cited barriers. Thus, SCS training should be customized to improve communication between oncology providers in the center and their patients and help the former convey the importance of SC to patients in a compelling and empathic manner. Other cited barriers (e.g., time) may be due to providers being under the impression that SCS is necessarily lengthy. Promoting a well-defined scope of basic activities that should collectively fall under SCS and that require a reasonable amount of time (and are feasible to perform within the local working environment) will also be useful.

Our study has some limitations. Its relatively small sample size limited meaningful subgroup analyses of AAR provision within strata such as profession or gender. Furthermore, although the data represent an important regional cancer hub, individual institutions may face other challenges. Nevertheless, our findings demonstrate—within an oncology setting that has not been studied previously in this context—a great deficiency in SCS provision and enable us to offer recommendations relevant to the region with regard to how SCS may be improved.

Author Contributions

Conception/Design: Nour A. Obeidat, Hiba S. Ayub, Susan Abughosh, Feras I. Hawari

Provision of study material or patients: Feras I. Hawari

Collection and/or assembly of data: Rula Amarin, Barakat Aburajab Altamimi, Iyad Ghonimat, Feras I. Hawari

Data analysis and interpretation: Nour A. Obeidat, Hiba S. Ayub, Rula Amarin, Barakat Aburajab Altamimi, Iyad Ghonimat, Susan Abughosh, Feras I. Hawari

Manuscript writing: Nour A. Obeidat, Hiba S. Ayub, Rula Amarin, Barakat Aburajab Altamimi, Iyad Ghonimat, Susan Abughosh, Feras I. Hawari

Final approval of manuscript: Nour A. Obeidat, Hiba S. Ayub, Rula Amarin, Barakat Aburajab Altamimi, Iyad Ghonimat, Susan Abughosh, Feras I. Hawari

Disclosures

The authors indicated no financial relationships.

References

  • 1.Fiore MC, Goplerud E, Schroeder SA. The Joint Commission’s new tobacco-cessation measures—will hospitals do the right thing? N Engl J Med. 2012;366:1172–1174. doi: 10.1056/NEJMp1115176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Goldstein AO, Ripley-Moffitt CE, Pathman DE, et al. Tobacco use treatment at the U.S. National Cancer Institute’s designated Cancer Centers. Nicotine Tob Res. 2013;15:52–58. doi: 10.1093/ntr/nts083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gritz ER, Fingeret MC, Vidrine DJ, et al. Successes and failures of the teachable moment: Smoking cessation in cancer patients. Cancer. 2006;106:17–27. doi: 10.1002/cncr.21598. [DOI] [PubMed] [Google Scholar]
  • 4.Gritz ER, Toll BA, Warren GW. Tobacco use in the oncology setting: Advancing clinical practice and research. Cancer Epidemiol Biomarkers Prev. 2014;23:3–9. doi: 10.1158/1055-9965.EPI-13-0896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Peters EN, Torres E, Toll BA, et al. Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Program Clinical Trials. J Clin Oncol. 2012;30:2869–2875. doi: 10.1200/JCO.2011.40.8815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Cooley ME, Lundin R, Murray L. Smoking cessation interventions in cancer care: Opportunities for oncology nurses and nurse scientists. Annu Rev Nurs Res. 2009;27:243–272. doi: 10.1891/0739-6686.27.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Cooley ME, Sipples RL, Murphy M, et al. Smoking cessation and lung cancer: Oncology nurses can make a difference. Semin Oncol Nurs. 2008;24:16–26. doi: 10.1016/j.soncn.2007.11.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Toll BA, Brandon TH, Gritz ER, et al. Assessing tobacco use by cancer patients and facilitating cessation: An American Association for Cancer Research policy statement. Clin Cancer Res. 2013;19:1941–1948. doi: 10.1158/1078-0432.CCR-13-0666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Lally RM, Chalmers KI, Johnson J, et al. Smoking behavior and patient education practices of oncology nurses in six countries. Eur J Oncol Nurs. 2008;12:372–379. doi: 10.1016/j.ejon.2008.04.008. [DOI] [PubMed] [Google Scholar]
  • 10.Sarna LP, Brown JK, Lillington L, et al. Tobacco interventions by oncology nurses in clinical practice: Report from a national survey. Cancer. 2000;89:881–889. [PubMed] [Google Scholar]
  • 11.Bandura A. doi: 10.1177/1090198104263660. Health promotion by social cognitive means. Health Educ Behav 2004, 31:143-164. [DOI] [PubMed] [Google Scholar]
  • 12.Association of American Medical Colleges Physician Behavior and Practice Patterns Related to Smoking Cessation: A Report Prepared for the American Legacy Foundation. 2007. Available at https://members.aamc.org/eweb/upload/Physician%20Behavior%20and%20Practice%20Patterns.pdf. Accessed January 12, 2013.
  • 13.Schnoll RA, Engstrom PF, Subramanian S, et al. Smoking cessation counseling by Russian oncologists: Opportunities for intervention in the Russian Federation. Int J Behav Med. 2006;13:8–15. doi: 10.1207/s15327558ijbm1301_2. [DOI] [PubMed] [Google Scholar]
  • 14.Weaver KE, Danhauer SC, Tooze JA, et al. Smoking cessation counseling beliefs and behaviors of outpatient oncology providers. The Oncologist. 2012;17:455–462. doi: 10.1634/theoncologist.2011-0350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Zapka JG, Fletcher KE, Ma Y, et al. Physicians and smoking cessation. Development of survey measures. Eval Health Prof. 1997;20:407–427. doi: 10.1177/016327879702000403. [DOI] [PubMed] [Google Scholar]
  • 16.Warren GW, Marshall JR, Cummings KM, et al. Addressing tobacco use in patients with cancer: A survey of American Society of Clinical Oncology members. J Oncol Pract. 2013;9:258–262. doi: 10.1200/JOP.2013.001025. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Oncologist are provided here courtesy of Oxford University Press

RESOURCES